Výsledky vyhledávání - "Luisa Fernanda Sánchez-Valledor"

Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center

Autor: Iván Murrieta-Álvarez, Juan Carlos Olivares-Gazca, Guillermo J. Ruiz-Argüelles, Andrés A. León-Peña, Yahveth Cantero-Fortiz, Montserrat Rivera-Álvarez, Alejandra Carmina Córdova-Ramírez, Luisa Fernanda Sánchez-Valledor, Thomas M. Habermann, Guillermo J. Ruiz-Delgado

Publikováno v: World Journal of Clinical Oncology

BACKGROUND The outcomes of Hodgkin´s lymphoma (HL) in México have not been widely reported. Simplified and affordable treatments have been adopted in middle-income countries. AIM The aim was to evaluate long-used therapies for HL in México in a lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8063ed0bf1f0646a0e2ce292a422d5f5
https://doi.org/10.5306/wjco.v12.i9.800

Zobrazit plný text záznamu

Mantle cell lymphoma may have a different clinical course in Mexican Mestizos: Real-world data from a single center

Autor: Iván Murrieta-Álvarez, Guillermo J. Ruiz-Argüelles, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Delgado, Andrés A. León-Peña, Luisa Fernanda Sánchez-Valledor, Alejandra Carmina Córdova-Ramírez, Montserrat Rivera-Álvarez, Gilberto David Elias-de-la-Cruz, Gerardo Colon-Otero, Juan Carlos Olivares-Gazca

Publikováno v: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 73(5)

Background The biology of some hematological diseases varies among different populations. No previous studies have evaluated the clinical behavior of mantle cell lymphoma (MCL) in Mexico. Objective and methods This is a retrospective review of MCL ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2746c172c89dab73a87fbae8c110996
https://pubmed.ncbi.nlm.nih.gov/33075042

Zobrazit plný text záznamu

Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment

Autor: Andrés Aurelio León-Peña, Juan Carlos Olivares-Gazca, Yahveth Cantero-Fortiz, Antonio Cruz-Mora, Luisa Fernanda Sánchez-Valledor, Guillermo J. Ruiz-Delgado, Dina Khalaf, Guillermo J. Ruiz-Argüelles, Iván Murrieta-Álvarez, Yarely Itzayana García-Navarrete

Publikováno v: Hematology (Amsterdam, Netherlands). 25(1)

Introduction: Although therapeutic choices for patients with chronic lymphocytic leukemia (CLL) were once limited, treatment of this disease has vastly improved in the last decades.Patients and met...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4aef250129985e0639835fc5be156e
https://pubmed.ncbi.nlm.nih.gov/32268849

Zobrazit plný text záznamu

Plný text ve formátu HTML

Development and Validation of Predictive Models for Transfusions in Hematopoietic Stem Cell Transplants for Autoimmune Disorders

Autor: Luisa Fernanda Sánchez-Valledor, Andrés A. León-Peña, Alejandra Carmina Córdova-Ramírez, Guillermo J Ruiz-Argüelles, Montserrat Rivera-Álvarez, Manuel Priesca-Marin, Iván Murrieta-Álvarez, Gilberto David Elias-de-la-Cruz, Yahveth Cantero-Fortiz, Martín Ojeda-Laguna, Guillermo J. Ruiz-Delgado

Publikováno v: Transplantation and Cellular Therapy. 27:S323-S324

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae8c5b162c67793e73556b095decbf31
https://doi.org/10.1016/s2666-6367(21)00414-0

Zobrazit plný text záznamu

Prognostic Features in Autografted People with Multiple Sclerosis Using an Outpatient Non-Myeloablative Regimen: Early Response Is Associated with Long-Term Improvement and Stabilization of Disease

Autor: Iván Murrieta-Álvarez, Montserrat Rivera-Álvarez, Yahveth Cantero-Fortiz, Andrés A. León-Peña, Alejandra Carmina Córdova-Ramírez, Luisa Fernanda Sánchez-Valledor, Gilberto David Elias-de-la-Cruz, Martín Ojeda-Laguna, Guillermo J Ruiz-Argüelles, Manuel Priesca-Marin, Guillermo J. Ruiz-Delgado, Juan Carlos Olivares-Gazca

Publikováno v: Transplantation and Cellular Therapy. 27:S322-S323

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f0fd1c14c3df7ec1087cfc421005002b
https://doi.org/10.1016/s2666-6367(21)00413-9

Zobrazit plný text záznamu

Chronic Lymphocytic Leukemia Treatment in México: Up to Half Patients May Not Requiere Treatment

Autor: Iván Murrieta-Álvarez, Juan Carlos Olivares-Gazca, Gilberto David Elias-de-la-Cruz, Carmina Alejandra Córdova-Ramírez, Andrés A. León-Peña, Antonio Cruz-Mora, Dina Khalaf, Luisa Fernanda Sánchez-Valledor, Guillermo J. Ruiz-Delgado, Montserrat Rivera-Álvarez, Guillermo J. Ruiz-Argüelles, Yahveth Cantero-Fortiz

Publikováno v: Blood. 136:36-37

Introduction Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm which represents the most frequent hematologic malignancy in Caucasians. Every year, there are15,000 new diagnoses and 5000 CLL deaths in the United States. Its prevalence in Méx

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90f451420debe282f08ffe2a544815f9
https://doi.org/10.1182/blood-2020-134066

Zobrazit plný text záznamu

Early Response Predicts Long-Term Improvement or Stabilization of Persons with Multiple Sclerosis Treated with Hematopoietic Stem Cell Transplantation

Autor: Gilberto David Elias-de-la-Cruz, Yahveth Cantero-Fortiz, Iván Murrieta-Álvarez, José Manuel Priesca-Marin, Andrés A. León-Peña, Montserrat Rivera-Álvarez, Luisa Fernanda Sánchez-Valledor, Guillermo J. Ruiz-Argüelles, Carmina Alejandra Córdova-Ramírez, Martín Ojeda-Laguna, Guillermo J. Ruiz-Delgado

Publikováno v: Blood. 136:13-14

Introduction: Hematopoietic stem cell transplantation (HSCT) has been widely employed for autoimmune disorders under myeloablative and non-myeloablative regimens. The main indication for HSCT in this setting is multiple sclerosis (MS) in its relapsin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d69338582fa22ca6c74e2274882890c
https://doi.org/10.1182/blood-2020-134056

Zobrazit plný text záznamu

Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Autor: Jesús Mauricio Olivares-Gazca, Andrés A. León-Peña, Iván Murrieta-Álvarez, Yarely Itzayana García-Navarrete, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles, Luisa Fernanda Sánchez-Valledor, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Juan Carlos Olivares-Gazca

Publikováno v: Biology of Blood and Marrow Transplantation. 26:S360

Introduction Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) that causes a whole spectrum of neurological disorders associated with a profound decrease in the quality of life

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::abffae61c7b7ba312ab8959fb489ad27
https://doi.org/10.1016/j.bbmt.2019.12.190

Zobrazit plný text záznamu

Hematopoietic Stem Cell Transplantation in Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data of a Prospective Study in a Single Institution

Autor: Juan Carlos Olivares-Gazca, Yarely Itzayana García-Navarrete, Iván Murrieta-Álvarez, Alejandro Ruiz-Argüelles, Lizsonette Medina de Jesús, Jesús Mauricio Olivares-Gazca, Andrés A. León-Peña, Guillermo J. Ruiz-Argüelles, Luisa Fernanda Sánchez-Valledor, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Delgado, David P. Steensma

Publikováno v: Biology of Blood and Marrow Transplantation. 26:S243

Introduction The treatment of patients with multiple myeloma (MM) has evolved in recent years, and the disease-associated prognosis has improved substantially. This improvement has been driven largely by the approval of novel agents, many of which ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::571923a2eab34ffdba7c84d0f192f797
https://doi.org/10.1016/j.bbmt.2019.12.490

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání